The widespread use of cannabis (marijuana) and its increased potency are associated with a rise in cannabis-related psychiatric conditions, according to a new University of Maryland School of Medicine (UMSOM) review article that was recently published in the New England Journal of Medicine.
Roche scrutinized by UK watchdog over ‘misleading’ Rozlytrek promotional website
The UK’s Prescription Medicines Code of Practice Authority (PMCPA) has ruled that a Roche webpage for its cancer medication Rozlytrek misled healthcare professionals. The allegations